{"entity":{"id":"medigene","kind":"company","name":"Medigene","aka":["MediGene AG","Medigene AG"],"tldr":"Medigene is a Munich-area biotech that develops T-cell receptor therapies and once sold a dendritic-cell vaccine programme; its earlier oncology products included the drug Veregen and phase 3 trials that carry its name.","summary":"Medigene AG, founded in 1994 and based in Planegg near Munich, discovers T-cell receptors for engineered T-cell therapies against solid tumours and licenses them to partners. Earlier it developed and sold Veregen (sinecatechins) and EndoTAG-1, a cationic liposomal paclitaxel taken to phase 3 in pancreatic cancer by its licensee, and ran a dendritic-cell vaccine programme in acute myeloid leukaemia. Its trials are registered on ClinicalTrials.gov under Medigene as lead sponsor.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://www.medigene.com"},{"label":"ClinicalTrials.gov: trials led by MediGene AG","url":"https://clinicaltrials.gov/search?lead=MediGene%20AG"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q1403929"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["pancreatic","aml"],"sections":[],"technologies":["tcr-t","dendritic-cell-vaccines"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Planegg","country":"DE","companyType":"cell-therapy","website":"http://www.medigene.com","founded":1994,"stage":"public","investors":[],"funding":[]},"route":"/companies/medigene/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"technology":[{"id":"dendritic-cell-vaccines","kind":"technology","name":"Dendritic cell vaccines","route":"/technologies/dendritic-cell-vaccines/"},{"id":"tcr-t","kind":"technology","name":"TCR-T cell therapy","route":"/technologies/tcr-t/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}